Cancer Biological Therapy Market size worth $100bn by 2023

1. Cancer Biological Therapy Market size worth $100bn by 2023

2. Cancer Biological Therapy Market size worth $100bn by 2023 • Cancer Biological Therapy Market size was USD 61.3 billion in 2015, with revenue forecast to cross USD 100 billion, at upwards of 6% growth from 2016 to 2023. • Rise in incidence rate of various cancers and growing adoption of biological therapy will drive the growth of the global cancer biological therapy market. • According to WHO, the number of new cancer cases is projected to rise 70% in the coming two decades, mainly due to increased use of tobacco and alcohol consumption.  • As per NCI, an estimated 16,85,210 new cases will be diagnosed in 2016, and about 5,95,690 individuals will succumb to the disease in the U.S. • Growing global geriatric population is predicted to boost biological cancer therapy market size owing to link between new cases and old age. Elderly population is more prone to the disease, and as per the ACS, 86% of cases in the U.S. were recorded in individuals aged 50 and above. • https://www.gminsights.com/industry-analysis/cancer-biological-therapy-market

3. Continue..... • This is due to accumulation of mutations in aged individuals body over time coupled with a reduction in the DNA mismatch repair process in hematopoietic stem cells (HSC). • The high treatment cost of oncology therapy is primarily due to high cost of drug development. Millions of dollars are spent in identifying or designing a drug, obtaining preclinical data and clinical trials. • It is estimated that each drug costs about USD 1.2 to USD 1.3 billion. • Monopoly is another factor contributing to high costs. • There are very few companies engaged in the manufacture of drugs resulting in reduced competition and higher prices, which restrains the global cancer biologic therapy market. • Cancer vaccines market was over USD 1.9 billion in 2015. Approval of the first vaccine sipuleucel-T (Provenge) for metastatic prostate cancer by the FDA will boost growth in the immunotherapy segment. • Get more detail @ https://www.gminsights.com/industry-analysis/cancer-biological-therapy-market

4. U.S. Cancer Biological Therapy Market size, by product, 2012 - 2023 (USD Million) https://www.gminsights.com/request-sample/detail/676

5. 360° Analysis • Product Analysis • Monoclonal antibodies market size was over USD 21 billion in 2015. Antibody therapy is the most successful and important approach for treatment of hematological malignance and  solid tumors. Bispecific monoclonal antibodies are anticipated to grow at  6.5% CAGR from 2016 to 2023. • Regional Analysis • Increased public funding for R&D and other government initiatives is expected to drive growth in North America over the forecast period. Germany cancer biological therapy market size was over USD 4.3 billion in 2015. It is expected to continue revenue share dominance due to increased prevalence and favorable public reimbursement and insurance policies. • Competitive Market Share • Novartis International Ag, Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb, GlaxoSmithKline Plc, F. Hoffmann-La Roche AG, Eli Lilly, Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc., Celgene Corporation are some notable companies vying for global cancer biological therapy market share. • Get more detail @ https://www.gminsights.com/industry-analysis/cancer-biological-therapy-market

6. Latest Research Report On Cancer Biological TherapyMarket@ https://www.gminsights.com/industry-analysis/cancer-biological-therapy-market Download Latest Report PDF @ https://www.gminsights.com/request-sample/detail/676

7. Stay In Touch You can visit us at: www.gminsights.com